Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Sabinsa to Showcase C3 Reduct, the Only EFSA-Approved Curcuminoid Ingredient - Nutraceuticals World
Live From

Vitafoods Europe

May 5, 2026 - May 7, 2026
|
Barcelona, Spain
Sponsored By
Vitafoods Europe

Sabinsa to Showcase C3 Reduct, the Only EFSA-Approved Curcuminoid Ingredient

The company will highlight several other botanical ingredients and its approach to the European market.

Booth A90
 
Sabinsa, a multinational supplier of nutraceutical ingredients, will showcase the company’s portfolio of ingredients at Vitafoods Europe 2024. As the official curcumin sponsor of the event, the company will highlight C3 Reduct, the only EFSA-approved curcuminoid ingredient approved by EFSA.
 
Other ingredients the supplier will showcase include:
 

  • Ciprusins, a Cyperus rotundus extract evidenced to support weight management, including in people with obesity;
  • Saberry, an amla extract standardized to 10% beta-glucogallin studied for its efficacy in supporting healthy lipid and glucose levels;
  • Nigellin, a Nigella sativa extract standardized for 5% and 20% Thymoquinone;
  • Shagandha, an ashwagandha extract standardized using USP methodology evidenced to support stress and anxiety.
 
“I am looking forward to meeting with our European customers at Vitafoods to discuss how our ingredients and expertise can support their brand success,” Shaheen Majeed, global CEO and managing director of Sabinsa.
 
Umar Jan, PhD, president of European Operations, will be present to discuss Sabinsa’s products, services, and sales support available to its European client base.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters